Bloom D D, Davignon J L, Retter M W, Shlomchik M J, Pisetsky D S, Cohen P L, Eisenberg R A, Clarke S H
Department of Microbiology and Immunology, University of North Carolina, Chapel Hill 27599.
J Immunol. 1993 Feb 15;150(4):1591-610.
Anti-Sm autoantibodies are unique to SLE, but are present in only 25% of patients with this disease. This response also occurs at a similar frequency in mice of the autoimmune MRL strains. Previous analyses of the anti-Sm response in these mice indicate that its occurrence is controlled by stochastic events, and suggest that Sm is the driving Ag. To further elucidate the role of Ag in this response, and to test the hypothesis that the 25% incidence is due to a requirement for particular Ig gene rearrangements or somatic mutations, we have analyzed the specificity and V-region gene sequences of 41 anti-Sm B cell hybridomas derived from nine anti-Sm-positive MRL/Mp-lpr/lpr mice. The majority of hybridomas are specific for the D peptide of the Sm particle. Hybridomas of independent origin express unique VH/V kappa combinations with diverse junctional sequences and are variable in the extent of somatic mutation. Thus, the response does not appear to be dependent upon the occurrence of a rare Ig gene rearrangement or specific somatic mutation. The response exhibits restriction in JH and VH gene use, and in individual mice is oligoclonal, suggestive of Ag selection. In the few B cells for which mutations can be identified, the evidence for selection of mutant B lymphocytes, based on patterns of mutation, is ambiguous. However, there is remarkably little intraclonal diversity, suggesting that the overall mutation rates in these clones are low.
抗Sm自身抗体是系统性红斑狼疮(SLE)所特有的,但仅在25%的该疾病患者中出现。这种反应在自身免疫性MRL品系小鼠中也以相似的频率发生。先前对这些小鼠中抗Sm反应的分析表明,其发生受随机事件控制,并提示Sm是驱动抗原。为了进一步阐明抗原在这种反应中的作用,并检验25%的发生率是由于特定Ig基因重排或体细胞突变的需求这一假说,我们分析了来自9只抗Sm阳性MRL/Mp-lpr/lpr小鼠的41个抗Sm B细胞杂交瘤的特异性和V区基因序列。大多数杂交瘤对Sm颗粒的D肽具有特异性。独立来源的杂交瘤表达独特的VH/Vκ组合,具有多样的连接序列,且体细胞突变程度各不相同。因此,这种反应似乎不依赖于罕见的Ig基因重排或特定的体细胞突变的发生。该反应在JH和VH基因的使用上表现出限制性,并且在个体小鼠中是寡克隆的,提示存在抗原选择。在少数能够鉴定出突变的B细胞中,基于突变模式选择突变B淋巴细胞的证据并不明确。然而,克隆内的多样性非常少,这表明这些克隆中的总体突变率很低。